factory low price Rapid Antigen Nasal - KaiBiLi COVID-19 Antigen – Genesis
factory low price Rapid Antigen Nasal - KaiBiLi COVID-19 Antigen – Genesis Detail:
Introduction
COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
The KaiBiLiTM COVID-19 Antigen Rapid Test Device is an in vitro diagnostic test based on the principle of immunochromatography for the qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of 2019 Novel Coronavirus. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infection.
This assay is intended for rapid screening in laboratory. This test should be conducted by trained technician, wearing appropriate personal protective equipment (PPE).
Detection
The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab.
Specimen
Nasal or nasopharyngeal
Limit of Detection (LoD)
2019 Novel Coronavirus: 140 TCID50/mL
ACCURACY （Nasal swab）
Positive Percent Agreement: 96.6%
Negative Percent Agreement:100%
Overall Percent Agreement: 98.9%
ACCURACY(Nasopharyngeal swab）
Positive Percent Agreement: 97.0%
Negative Percent Agreement:98.3%
Overall Percent Agreement: 97.7%
Time to Results
Read results at 15minutes and no more than 30 minutes.
Kit storage conditions
2~30°C.
Contents
|
Description |
Qty |
| COVID-19 antigen test devices |
20 |
| Sterilized swabs |
20 |
| Extraction tubes (with 0.5mL extraction buffer) |
20 |
| Nozzles with filter |
20 |
| Tube Stand |
1 |
| Package Insert |
1 |
Ordering Information
|
Product |
Cat.No. |
Contents |
|
KaiBiLiTM COVID-19 Antigen |
P211139 |
20 Tests |
Product detail pictures:
Related Product Guide:
While in the past few years, our organization absorbed and digested innovative technologies both equally at home and abroad. Meanwhile, our organization staffs a group of experts devoted for the advancement of factory low price Rapid Antigen Nasal - KaiBiLi COVID-19 Antigen – Genesis , The product will supply to all over the world, such as: Haiti, Jordan, New Zealand, Now, with the development of internet, and the trend of internationalization, we've got decided to extend business to overseas market. With the propose of bringing more profits to oversea customers by providing directly abroad. So we have changed our mind, from home to abroad, hope to give our customers more profit, and looking forward to more chance to make business.
By Paula from Barbados - 2017.12.19 11:10
This manufacturer can keep improving and perfecting products and service, it is in line with the rules of market competition, a competitive company.
By Delia from Kuwait - 2017.08.15 12:36
